0001238403-21-000002.txt : 20210528
0001238403-21-000002.hdr.sgml : 20210528
20210528184814
ACCESSION NUMBER: 0001238403-21-000002
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210527
FILED AS OF DATE: 20210528
DATE AS OF CHANGE: 20210528
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SPIEGELMAN DANIEL K
CENTRAL INDEX KEY: 0001238403
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26642
FILM NUMBER: 21982240
MAIL ADDRESS:
STREET 1: MYRIAD GENETICS
STREET 2: 320 WAKARA WAY
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84003
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MYRIAD GENETICS INC
CENTRAL INDEX KEY: 0000899923
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 870494517
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 320 WAKARA WAY
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84108
BUSINESS PHONE: 801-584-3600
MAIL ADDRESS:
STREET 1: 320 WAKARA WAY
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84108
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2021-05-27
0
0000899923
MYRIAD GENETICS INC
MYGN
0001238403
SPIEGELMAN DANIEL K
320 WAKARA WAY
SALT LAKE CITY
UT
84108
1
0
0
0
Common Stock
2021-05-27
4
D
0
15889
0.0
D
20562
D
On May 27, 2021, the Company rescinded Mr. Spiegelman's grant of 15,889 restricted stock units granted on December 4, 2020 and reported on the Form 4 filed with the Securities and Exchange Commission on December 7, 2020.
By: Nathan A. Smith For: Daniel K. Spiegelman
2021-05-28